Detalhe da pesquisa
1.
No clear effect of postoperative radiotherapy on survival of breast cancer patients with one to three positive nodes: a population-based study.
Ann Oncol
; 26(6): 1149-1154, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25839671
2.
Oestrogen receptor co-activator AIB1 is a marker of tamoxifen benefit in postmenopausal breast cancer.
Ann Oncol
; 24(8): 1994-9, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23670096
3.
Overall survival benefit for sequential doxorubicin-docetaxel compared with concurrent doxorubicin and docetaxel in node-positive breast cancer--8-year results of the Breast International Group 02-98 phase III trial.
Ann Oncol
; 24(5): 1203-11, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23293111
4.
Time dependent effects of adjuvant tamoxifen therapy on cerebrovascular disease: results from a randomised trial.
Br J Cancer
; 104(6): 899-902, 2011 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21343938
5.
Prognostic utility of HOXB13:IL17BR and molecular grade index in early-stage breast cancer patients from the Stockholm trial.
Br J Cancer
; 104(11): 1762-9, 2011 May 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-21559019
6.
Survival patterns of invasive lobular and invasive ductal breast cancer in a large population-based cohort with two decades of follow up.
Breast
; 59: 294-300, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34388695
7.
Hypoxia, Snail and incomplete epithelial-mesenchymal transition in breast cancer.
Br J Cancer
; 101(10): 1769-81, 2009 Nov 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-19844232
8.
Effects of adjuvant tamoxifen over three decades on breast cancer-free and distant recurrence-free interval among premenopausal women with oestrogen receptor-positive breast cancer randomised in the Swedish SBII:2pre trial.
Eur J Cancer
; 110: 53-61, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30769227
9.
Amplification of CCND1 and PAK1 as predictors of recurrence and tamoxifen resistance in postmenopausal breast cancer.
Oncogene
; 26(49): 6997-7005, 2007 Oct 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-17486065
10.
Is risk of central nervous system (CNS) relapse related to adjuvant taxane treatment in node-positive breast cancer? Results of the CNS substudy in the intergroup Phase III BIG 02-98 Trial.
Ann Oncol
; 19(11): 1837-41, 2008 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-18562328
11.
Adjuvant goserelin in pre-menopausal patients with early breast cancer: Results from the ZIPP study.
Eur J Cancer
; 42(7): 895-904, 2006 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-16545560
12.
Estradiol receptor analysis in human breast cancer tissue by isoelectric focusing in polyacrylamide gel.
Cancer Res
; 38(11 Pt 2): 4225-8, 1978 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-29706
13.
A novel p53 germline alteration identified in a late onset breast cancer kindred.
Oncogene
; 13(2): 407-11, 1996 Jul 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-8710380
14.
Expression of the deleted in colorectal cancer gene is related to prognosis in DNA diploid and low proliferative colorectal adenocarcinoma.
J Clin Oncol
; 17(6): 1745-50, 1999 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-10561211
15.
The relationship between hormone receptor content and the effect of adjuvant tamoxifen in operable breast cancer.
J Clin Oncol
; 7(10): 1474-84, 1989 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-2674335
16.
S-phase fraction is a prognostic factor in stage I breast carcinoma.
J Clin Oncol
; 11(9): 1717-22, 1993 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-8355038
17.
Pathology parameters and adjuvant tamoxifen response in a randomised premenopausal breast cancer trial.
J Clin Pathol
; 58(11): 1135-42, 2005 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-16254100
18.
K-ras mutations in colorectal adenocarcinomas and neighbouring transitional mucosa.
Eur J Cancer
; 34(13): 2053-7, 1998 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-10070310
19.
Cellular accumulation of p53 protein: an independent prognostic factor in stage II breast cancer.
Eur J Cancer
; 30A(2): 175-80, 1994.
Artigo
em Inglês
| MEDLINE | ID: mdl-7908819
20.
Prognostic significance of p53 nuclear and cytoplasmic overexpression in right and left colorectal adenocarcinomas.
Eur J Cancer
; 32A(11): 1963-7, 1996 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-8943682